A new approach to antidepressants and anxiolytics: the microbiota-gut-brain axis

Our understanding of anxiety and depression has evolved over the years, leading to advancements in diagnosis, treatment, and clinical management. However, their prevalence has not lessened; in fact, it has heightened in recent years due to the COVID-19 pandemic. Its effects will last for years to come, so all mechanisms that can influence its incidence

Read more…

A new approach to antidepressants and anxiolytics: the microbiota-gut-brain axis originally appeared in KevinMD.com.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.